Project Details
| Short title | OP-1250-302 |
|---|---|
| Acronym | OPERA-02 |
| Status | Active |
| Effective start/end date | 4/11/25 → 25/09/30 |
CTU: A Phase 3 Randomized, Double-Blind, Active-Controlled Study of Palazestrant with Ribociclib Versus Letrozole with Ribociclib for the First-Line Treatment of ER+, HER2– Advanced Breast Cancer (OPERA- 02)
- Sabanathan, Dhanusha (Primary Chief Investigator)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
- Lawrie, Angus (Clinical Trial Unit Staff)
- Delahunt Smoleniec, Jacqui (Clinical Trial Unit Staff)
Project: Research